Ann Dermatol.  2013 Nov;25(4):489-492. 10.5021/ad.2013.25.4.489.

New Onset Guttate Psoriasis Following Pandemic H1N1 Influenza Vaccination

• Shin MS
• Kim SJ
• Kim SH
• Kwak YG
• Park HJ

• KMID: 2265066
• DOI: http://doi.org/10.5021/ad.2013.25.4.489

Abstract

Since the introduction of H1N1 influenza vaccine in the wake of the 2009 H1N1 pandemic, many serious and non-serious vaccine-related adverse events have been reported. The vaccination could induce pain, erythema, tenderness, and induration on injected areas. These symptoms usually disappear in a few days after the vaccination. In this case, we observed a 26-year-old woman with multiple erythematous scaly macules scattered on the extremities and trunk. She was injected with an inactivated split-virus influenza A/H1N1 vaccine without adjuvant (Greenflu-S(R), Green Corp.) on her left deltoid area 10 days earlier. The first lesion appeared on the injection site three days after the vaccination, and the following lesions spread to the trunk and extremities after a few days. Histopathological examinations showed neutrophilic collections within the parakeratotic cornified layer, moderate acanthosis, diminished granular layer, elongation and edema of the dermal papillae, and dilated capillaries. The lesions were successfully treated with topical steroids and ultraviolet B phototherapy within three weeks, and there was no relapse for the following fourteen months. We assumed that pandemic vaccination was an important trigger for the onset of guttate psoriasis in this case.

Keyword

Psoriasis; Vaccination

MeSH Terms

Adult
Capillaries
Edema
Erythema
Extremities
Female
Humans
Influenza Vaccines
Influenza, Human*
Neutrophils
Pandemics*
Phototherapy
Psoriasis*
Recurrence
Steroids
Vaccination*
Influenza Vaccines
Steroids

Figure

• 

  Fig. 1 (A) Multiple erythematous small scaly macules on trunk. (B) Larger lesion at the site of vaccination.

• 

  Fig. 2 (A) Skin biopsy specimen showed parakeratosis, moderate acanthosis and rete ridge elongation in epidermis and perivascular infiltration of inflammatory cells in upper dermis (H&E, ×100). (B) Neutrophililc collection within the parakeratotic cornified layer, Munro's microabscess (H&E, ×200).

Reference

1. Raaschou-Nielsen W. Psoriasis vaccinalis; report of two cases, one following B.C.G. vaccination and one following vaccination against influenza. Acta Derm Venereol. 1955; 35:37–42.

2. Bogdaszewska-Czabanowska , Brzewski M. Psoriasis vaccinalis (post-BCG). Przegl Dermatol. 1973; 60:497–499.

3. Queiro R, Ballina J, Weruaga A, Fernández JA, Riestra JL, Torre JC, et al. Psoriatic arthropathy after BCG immunotherapy for bladder carcinoma. Br J Rheumatol. 1995; 34:1097.

4. Koca R, Altinyazar HC, Numanoğlu G, Unalacak M. Guttate psoriasis-like lesions following BCG vaccination. J Trop Pediatr. 2004; 50:178–179.

5. Dudelzak J, Curtis AR, Sheehan DJ, Lesher JL Jr. New-onset psoriasis and psoriatic arthritis in a patient treated with Bacillus Calmette-Guérin (BCG) immunotherapy. J Drugs Dermatol. 2008; 7:684.

6. Takayama K, Satoh T, Hayashi M, Yokozeki H. Psoriatic skin lesions induced by BCG vaccination. Acta Derm Venereol. 2008; 88:621–622.

7. Oh CE, Lee J, Kang JH, Hong YJ, Kim YK, Cheong HJ, et al. Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to <18 years of age: a prospective, open-label, multi-center trial. Vaccine. 2010; 28:5857–5863.

8. Mubki TF, Bin Dayel SA, Kadry R. A case of Pityriasis rosea concurrent with the novel influenza A (H1N1) infection. Pediatr Dermatol. 2011; 28:341–342.

9. Kwon NH, Kim JE, Cho BK, Park HJ. A novel influenza a (H1N1) virus as a possible cause of pityriasis rosea? J Eur Acad Dermatol Venereol. 2011; 25:368–369.

10. Chen JF, Chiang CP, Chen YF, Wang WM. Pityriasis rosea following influenza (H1N1) vaccination. J Chin Med Assoc. 2011; 74:280–282.

11. Böhle A, Brandau S. Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer. Philadelphia: Elsevier Sauders;2012. p. 135–156.

12. Bolognia J, Jorizzo JL, Schaffer JV. Dermatology. 3rd ed. Philadelphia: Elsevier Saunders;2012. p. 135–156.

13. Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 2007; 445:648–651.

14. Hamouda T, Chepurnov A, Mank N, Knowlton J, Chepurnova T, Myc A, et al. Efficacy, immunogenicity and stability of a novel intranasal nanoemulsion-adjuvanted influenza vaccine in a murine model. Hum Vaccin. 2010; 6:585–594.

15. Telfer NR, Chalmers RJ, Whale K, Colman G. The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol. 1992; 128:39–42.

16. MedlinePlus. Trusted Health Information for you [Internet]. Bethesda (MD): National Library of Medicine (US); Antistreptolysin O titer;updated 2011 Aug 29. cited 2011 Sep 1. Available from: http://www.nlm.nih.gov/medlineplus/ency/article/003522.htm.